Study Evaluating The Safety And Effectiveness In Subjects With Tigecycline Treatment
Status:
Completed
Trial end date:
2015-04-01
Target enrollment:
Participant gender:
Summary
The primary objective of this study is to identify any changes on the safety profile of
adverse events and serious adverse events. And the secondary objective is to evaluate
clinical response in the clinically evaluable population at test-of cure (TOC) or at the end
of treatment (EOT) assessment, and microbiologic response at the subject level, if available.